• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG PROSA VALVE; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG PROSA VALVE; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV701T
Device Problem Infusion or Flow Problem (2964)
Patient Problem Hydrocephalus (3272)
Event Date 08/22/2021
Event Type  Injury  
Manufacturer Narrative
Manufacturing and quality control data: the prosa® was manufactured by a qualified employee in january 2015.Deviations during assembly did not occur.The valve was sterilized by miethke and released for shipment after final inspection.The prosa® has a normal pressure range of 0 to 40 cmh2o.The valve was inspected as article fv701t.All parameters have been inspected and approved during the manufacturing process.All parameters have been assessed as meeting specifications.Incoming product condition: the valve was received submersed in an unidentified liquid in the provided returnkit.The complaint device was strongly contaminated with bloody liquid and tissue residues.Results: testing of contaminated valves are of limited value.The device characteristics may be influenced by the presence of cerebrospinal fluid or blood residues.As previously indicated, the complaint sample was received submerged in a bloody liquid and was contaminated with tissue residue.Subsequently, the device was classified as high risk to staff and for hygiene reasons, a device evaluation was not able to be performed.Therefore, a definitive conclusion regarding the complaint incident was unable to be reached without a physical examination of the complaint device.Although the device was not evaluated, it is possible that protein deposits inside the valve affected the function of the prosa® valve.As described in scientific literature, the problem encountered is one of the known, inevitable risks of hydrocephalus therapy (hc-therapy) by shunt implants.Manufacturing defects at the time of release have been excluded.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
 
Event Description
It was reported that a prosa valve (part # fv701t) was implanted during a procedure performed on (b)(6) 2017.According to the complainant, a blockage of the valve was suspected and the shunt system was believed to be operating in underdrainage.The patient underwent a revision procedure on (b)(6) 2021.The complaint device was returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Age: (b)(6), height: (b)(6), weight: (b)(6), gender: unknown.Same patient as # 3004721439-2021-00267.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROSA VALVE
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key12535100
MDR Text Key275133175
Report Number3004721439-2021-00266
Device Sequence Number1
Product Code JXG
UDI-Device Identifier04041906133023
UDI-Public4041906133023
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K161853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 09/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/14/2020
Device Model NumberFV701T
Device Catalogue NumberFV701T
Device Lot Number20025471
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/06/2021
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/06/2021
Initial Date FDA Received09/27/2021
Was Device Evaluated by Manufacturer? No
Date Device Manufactured01/13/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age44 YR
Patient Weight70
-
-